Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer"
Eur J Cancer
.
2013 Nov;49(16):3575-6.
doi: 10.1016/j.ejca.2013.08.010.
Epub 2013 Sep 4.
Authors
G Zucchini
1
,
S Quercia
,
C Zamagni
,
D Santini
,
M Taffurelli
,
S Fanti
,
A A Martoni
Affiliation
1
Medical Oncology Unit, S. Orsola-Malpighi University Hospital, Bologna, Italy. Electronic address:
[email protected]
.
PMID:
24011537
DOI:
10.1016/j.ejca.2013.08.010
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / diagnosis*
Breast Neoplasms / metabolism*
Female
Fluorodeoxyglucose F18*
Humans
Multimodal Imaging / methods*
Positron-Emission Tomography*
Tomography, X-Ray Computed*
Substances
Fluorodeoxyglucose F18